Despite the market volatility, shares in Abclon Inc (KOSDAQ:174900) have been in an uptrend in recent months. The question now for investors is whether that price strength will continue. Finding stocks with the potential to break-out a...
174900 — AbClon Share Price
- KR₩294bn
- KR₩283bn
- KR₩2bn
Momentum
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | |||
EPS Growth (f) | |||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | |||
Price to Tang. Book | |||
Price to Free Cashflow | |||
Price to Sales | |||
EV to EBITDA |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | |||
Return on Equity | |||
Operating Margin |
Financial Summary
Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 3,120.33 | 3,532.43 | 3,920.79 | 14,375.03 | 2,771.18 | 5,000 | n/a | 7.3% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Latest News & Insights for 174900
If you've ever found yourself feeling increasingly drawn to a stock that's constantly rising in price, you are not alone... Since the dawn of the stock market, speculators have been captured by the tendency of prices to 'trend'. When...
Profile Summary
AbClon Inc. is a Korea-based company principally engaged in the development, manufacture and distribution of antibody drug. The Company developed a bio synergy antibody, a therapeutic antibody for a new mechanism that is different from conventional therapeutic agents, and is based on the YPLUS and AffiMab platforms. The company's products include AC101, AC103, AC104, AC106, AC203, AM201, AM101, AM102 and AM103. The Company distributes its products within domestic market and to overseas markets.
Directors
- Last Annual
- December 31st, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- June 25th, 2010
- Public Since
- September 18th, 2017
- No. of Shareholders
- 27,799
- No. of Employees
- 53
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 15,278,069
- Address
- SEOUL, 08381
- Web
- http://www.abclon.co.kr/
- Phone
- +82 221091294
- Auditors
- Ernst & Young Han Young
Upcoming events for 174900
Similar to 174900
ALTEOGEN ORD
Korea Exchange - KOSDAQ
ANTEROGEN ORD
Korea Exchange - KOSDAQ
BIO SOLUTION ORD
Korea Exchange - KOSDAQ
BNC ORD
Korea Exchange - KOSDAQ
CELLTRION HEALTH ORD
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:54 UTC, shares in AbClon are trading at KR₩19,250. This share price information is delayed by 15 minutes.
Shares in AbClon last closed at KR₩19,250 and the price had moved by -45.6% over the past 365 days. In terms of relative price strength the AbClon share price has underperformed the FTSE Developed Asia Pacific Index by -57.13% over the past year.
The overall consensus recommendation for AbClon is Buy. You can view the full broker recommendation list by unlocking its StockReport.
AbClon does not currently pay a dividend.
AbClon does not currently pay a dividend.
AbClon does not currently pay a dividend.
To buy shares in AbClon you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩19,250, shares in AbClon had a market capitalisation of KR₩294bn.
Here are the trading details for AbClon:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 174900
Based on an overall assessment of its quality, value and momentum AbClon is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AbClon. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -38.72%.
As of the last closing price of KR₩19,250, shares in AbClon were trading -31.18% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for AbClon.
We do not have data on AbClon's directors
We do not have data on AbClon's shareholders